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Abstract
Background: Colour Doppler analysis of ophthalmic vessels has been proposed as a promising tool in the diagnosis
of various eye diseases, but the available diagnostic evidence has not yet been assessed systematically. We
performed a comprehensive systematic review of the literature on the diagnostic properties of Colour
Doppler imaging (CDI) assessing ophthalmic vessels and provide an inventory of the available evidence.
Methods: Eligible papers were searched electronically in (Pre) Medline, Embase and Scopus, and via cross-
checking of reference lists. The minimum requirement to be included was the availability of original data
and the possibility to construct a two-by-two table. Study selection, critical appraisal using the QUADAS II
instrument and extraction of salient study characteristics was made in duplicate. Sensitivity and specificity
was computed for each study.
Results: We included 11 studies (15 two-by-two tables) of moderate methodological quality enrolling 820
participants (range 30 to 118). In 44.4% participants were female (range 37–59% in specific subgroups). CDI
was assessed for internal carotid stenosis, diabetic retinopathy, glaucoma, and branch or central retinal vein
occlusion diagnosis. There was insufficient data to pool the results for specific illnesses. For the assessments
of ophthalmic arteries, mean sensitivity was 0.69 (range 0.27–0.96) with a corresponding mean specificity of 0.
83 (range 0.70–0.96). Mean sensitivity of the central retinal artery assessments was 0.58 (range 0.31–0.84) and
the corresponding mean specificity was 0.82 (range 0.63–0.94).
Conclusions: Robust assessments of the diagnostic value of colour Doppler analysis remain uncommon,
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Background
Colour Doppler analysis of ophthalmic vessels has
been proposed as a promising tool in the diagnosis
of various eye diseases [1]. Colour Doppler imaging
(CDI) enables ophthalmologists to examine ocular
blood flow, even in presence of dense ocular opaci-
ties preventing a direct view to the posterior eye
segment [2]. Compared to fluorescein angiography
(FA), CDI allows for assessing the ocular blood flow
in a non-invasive manner. Numerous studies have
examined changes in ocular blood flow velocities in
various diseases affecting the eye such as carotid
artery and retinal vein occlusion, diabetic retinopathy
(DRP) and glaucoma, and have revealed significant
differences compared to healthy subjects even in
early stages of disease (reviewed in [3, 4]). As an
example, Evans and colleagues [5] demonstrated that
diabetic patients with minimal or no retinopathy
demonstrate irregular flow levels in the major vessels
feeding the eye.
However, despite several potential benefits, CDI has
not accomplished to make the leap into daily ophthal-
mic routine. Inter-observer variability issues could be
a possible explanation [6]. Although updated assess-
ment protocols have enhanced CDI inter-observer
variability performance, [7] this remains a limiting
factor for implementation in daily clinical use. An-
other problem relates to the fact that evidence on
diagnostic accuracy is scattered among the various
clinical fields and presumably not easy to access. For
this reason we performed a comprehensive systematic
review of the diagnostic literature on ophthalmic
Doppler analysis, with special reference to the diag-
nostic merits of the technique, and provide an inven-
tory of the available evidence.
Methods
This review has been conducted according to the
PRISMA statement recommendations. The review
protocol has been registered on Prospero [8] (PROSPERO
2014:CRD42014014027).
Literature search
An information specialist performed electronic
searches without any language restrictions on (pre)-
MEDLINE (PubMed interface), Scopus and Embase
(Ovid-Interface). The full search algorithms for the
three databases are provided in the Appendix.
Searches were performed on the 11th November 2014
and updated on the 4th of May 2016.
Eligibility criteria
We excluded studies assessing only healthy subjects,
animal studies and studies without primary focus on
eye diseases. We included case-control and cohort
studies. The minimum requirement was the availabil-
ity of original data and the possibility to construct a
two-by-two table. We accepted the following refer-
ence tests classifying disease presence: carotid angiog-
raphy, carotid ultrasound, fundoscopy, Humphrey
visual field analyser, fluorescein angiography and
Heidelberg retina optical coherence tomography.
Study selection, data extraction and quality assessment
Based on the QUADAS II criteria all eligible papers
were judged for their quality using four suggested do-
mains (patient selection, index test, reference standard
and flow and timing) [9]. The instrument assesses the
risk of bias of each domain. Moreover, the analysis of
patient selection, the index test and the reference test
examine the extent of applicability. The tool is
broadly applied to standardise the rating of bias and
to weigh applicability of diagnostic accuracy studies.
We followed the recommendations of Whiting and
colleagues [9] and refrained from rating or ranking of
studies. Two reviewers independently read and assessed
papers and extracted data using a standardized data ab-
straction form. Discrepancies were resolved by consensus
between the two reviewers.
Statistical analysis
For each study, we constructed a two-by-two contin-
gency table consisting of true-positive (TP), false-
positive (FP), false-negative (FN), and true-negative
(TN) results. For the analysis, we called a result a
true positive if the CDI finding was concordant and
in agreement with the reference standard findings.
We calculated sensitivity as TP/(TP + FN) and specifi-
city as TN/(FP + TN).
Meta- analysis
Formal pooling was only planned if at least four stud-
ies reported accuracy parameters for the diagnosis of
a specific illness. However, in an exploratory meta-
analysis of sensitivity and specificity using a multilevel
mixed-effects logistic regression model (metandi com-
mand in Stata), we calculated diagnostic summary
estimates mainly of the resistance index measured
either in the ophthalmic or the central retinal artery
irrespective of the underlying condition. This was
done to gain an overall impression about the discrim-
inatory potential of the technology rather than to
inform clinical practice.
All analyses were done using the Stata 14.1 statistical
software package (StataCorp. 2015. Stata Statistical Soft-
ware: Release 14. College Station, TX: StataCorp LP.).
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Results
Study selection
Electronic searches retrieved 3471 records. After ex-
cluding duplicates, 2239 records remained. Screening
of titles and abstracts excluded 2224 studies as they
did not investigate the diagnostic accuracy of tests,
investigated other conditions, or contained no primary
data. Full texts of fifteen articles were read. Five of
these studies did not meet the inclusion criteria and
were excluded. The ten remaining articles were com-
pleted by addition of another study found via the
screening of reference lists. In total, thus, 11 studies
were included in this systematic review. Figure 1
shows the study selection process.
Quality of included studies
We assessed the quality of the included studies using
the QUADAS II tool considering four criteria (patient
selection, index test, reference standard and flow and
timing). The reference standard was appropriate in all
selected trials, whereas flow and timing of the studies
was inconsistent, mostly due to long periods of dis-
ease onset to performance of index- and reference
tests. Most studies scored low for the items patient
selection and rating of the index test. In case of
patient selection this was partly due to a lack of age
and sex matched study groups and partly due to not
describing exclusion criteria. Low ratings regarding
the index test were related to cut-off points that were
not pre-specified and to the fact that not all investi-
gators performed the index test being unaware of the
diagnosis. Table 1 outlines the results of the quality
assessment according to QUADAS II criteria.
Patients’ characteristics, design features
The 11 selected studies enrolled 820 patients. Among
the studies which reported this, 44.4% of participants
were women ranging from 11 to 75%. Study size
ranged between 30 and 118 subjects. Four studies
included patients consecutively. The most commonly
Fig. 1 Study selection process (PRISMA Statement flowchart)
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Table 1 Study characteristics, patient population








Han-Hwa Hu, 1993 [10] CIS <50%: n = 84; CIS 50–74%:
n = 23; CIS 75–99%: n = 17;
CIS 100%: n = 8
Cross sectional study n.r. 132 63 11% 2 2 1 1
Paivansalo,1999 [11] both side CIS <80%:
n = 46 ; at least one side
CIS >80%:n = 48
Cross sectional study n.r. 94 63.1 38% 2 2 1 1
Arai, 1998 [12] DM without DRP: n = 27, DRP:
n = 25
Cross sectional study n.r. 52 DM without DRP: 50.0,
DRP: 56.1
45% 1 2 1 3
Basturk, 2012 [13] DM II without DRP: n = 40,
DRP: n = 51, healthy subjects:
n = 27






1 2 1 3
Jimenez-Aragon, 2013 [14] Early glaucoma no-
progression group: n = 59;
early glaucoma progression
group: n = 12
Longitudinal and
prospective study






1 1 1 3
Arsène, 2002 [18] CRVO-ischaemic: n = 18;
CRVO-non-ischaemic: n = 51;




n.r. 102 61 38% 2 1 1 2
Tranquart, 1999 [19] CRVO-ischemic: n = 18; CRVO:
non-ischaemic: n = 51
Cross sectional study n.r. 69 61 (based on 102
subjects)
38% (based on 102
subjects)
2 1 1 3
Plange, 1999 [17] NTG: n = 62; healthy controls:
n = 40
Cross-sectional study yes 102 NTG: 57, healthy
subjects: 58
37% 1 1 1 1
Martinez, 2005 [15] POAG progression group:
n = 23; POAG no-progression
group: n = 26
Prospective cohort
study
yes 49 63.7 53% 1 3 1 1
Suprasanna, 2014 [16] POAG-progression group:
n = 25; POAG no-progression-
group: n = 53
Case control study n.r. 78 62.6 41% 2 2 1 1
Williamson, 1994 [6] CRVO without iris
neovascularization: n = 22,
CRVO with iris
neovascularization: n = 8
Prospective cohort
study
n.r. 30 67.2 (based on 80
patients)
49% (based on 80
subjects)
1 2 1 2
n.r. not reported, CIS carotis interna stenosis, DM diabetes mellitus, DRP diabetic retinopathy, CRVO central retinal vein occlusion, NTG normal tension glaucoma, POAG primary open angle glaucoma, 1 = low risk,













described co-morbidities (other than the assessed
illness) were hypertension and diabetes. Patients’
characteristics are summarized in Table 1.
Index and reference tests
Two studies assessed the possibility of a >75% or >80%
internal carotid stenosis (ICS) diagnosis [10, 11]. An-
other two trials assessed the diagnosis of DRP.
Whereas Arai et al. [12] examined the diagnosis of
DRP among patients suffering from non-insulin-
dependent diabetes, Basturk and colleagues [13] in-
vestigated the diagnosis of DRP in patients suffering
from diabetes type II with microalbuminuria. Predic-
tion of glaucoma progression was investigated in
three studies two using the Humphrey field analyser
and one the Heidelberg retina tomography as the ref-
erence test [14–16]. One study aimed to distinguish
normal tension glaucoma from healthy eyes [17]. In
another two studies, fluorescein angiography was set
as the reference test assessing diagnosis of branch or
central retinal vein occlusion (BRVO, CRVO) and
diagnosis of ischemic CRVO respectively [18, 19].
Arséne et al. [18] aimed to distinguish eyes with
CRVO from eyes with BRVO. Gonioscopy and slit
lamp examination were set as reference tests in one
study predicting iris vascularization 1 year after
CRVO onset [6]. Table 2 shows the applied index and
reference tests of each study.
Index test parameters assessed
Of the four studies assessing glaucoma, two used the
resistive index (RI) to evaluate test accuracy of glau-
coma progression [15, 16]. Another study used
diastolic velocity to distinguish between normal
tension glaucoma (NTG) and healthy eyes [6] and
one study used a logistic discrimination function to
predict the progression of glaucomatous damage [14].
Of the two studies assessing ICS, one used peak flow
velocity [10] and one the RI [11]. Both studies exam-
ining the diagnostic value of CDI in DRP used RI as
investigational parameter [12, 13]. Two studies asses-
sing ischemia and neovascularization after CRVO,
used the parameter “minimum velocity” [6, 19]. One
study assessed the possibility to distinguish between
CRVO and BRVO used the RI [18].
Test performance characteristics
Among studies assessing the ophthalmic artery (OA)
flow, mean sensitivity was 0.69 (range 0.27–0.96) with
a corresponding mean specificity of 0.83 (range 0.70–
0.96), whereas for central retinal artery (CRA) flow
measurements, mean sensitivity was 0.58 (range 0.31–
0.84) with a corresponding specificity of 0.82 (range
0.63–0.94). The range of the number of eyes assessed
in studies examining OA was 49 to 132, and 52 to
132 in studies assessing CRA. Assessments of the
central retinal vein (CRV) reported sensitivities
ranging from 0.67 to 0.75 and specificities of 0.65 to
0.86 in 30 and 69 eyes respectively. All test perform-
ance characteristics are outlined in Table 3.
Results from exploratory meta-analysis
Formal pooling of results for specific illnesses was
impossible due to the limited number of studies. In
the exploratory meta-analysis of studies investigating
the OA across different illnesses, the pooled estimated
Table 2 Summary of index and reference tests applied in included studies
Name, year Index test Reference tests
CDI CA cCDI FS HRT GAT SLE FLA HFA GS
Han-Hwa Hu, 1993 [10] x x x
Paivansalo, 1999 [11] x x
Arai, 1998 [12] x x
Basturk, 2012 [13] x x
Jimenez-Aragon, 2013 [14] x x
Arsène, 2002 [18] x x x x
Tranquart, 1999 [19] x x x x
Plange, 1999 [17] x x x
Martinez, 2005 [15] x x
Suprasanna, 2014 [16] x x
Williamson, 1994 [6] x x x
CDI colour doppler imaging, CA carotid angiography, cCDI carotid colour doppler imaging, FS fundoscopy, HRT Heidelberg retina tomograph, GAT Goldmann
applanations tonometry, SLE slit lamp examination, FLA flourescein angiography, HFA Humphrey field analyzer, GS gonioscopy
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sensitivity was 0.72 (95% CI; 0.52 to 0.86) with a cor-
responding specificity of 0.85 (95% CI; 0.76 to 0.90).
The analysis of the CRA revealed a lower sensitivity
of 0.58 (95% CI; 0.43 to 0.72) and a comparable spe-
cificity of 0.85 (95% CI; 0.74 to 0.91) (see Fig. 2).
Discussion
Main findings
The results of a small number of studies with only
few patients suggest that the diagnostic value of
colour Doppler analysis in ophthalmology is limited.
Diagnostic performance varies considerably between
studies illnesses with slightly better results when
assessing the OA. Even though alterations of ocular
blood flow could be used as a valuable tool in diag-
nosing ocular pathologies their acquisition remains a
technical challenge and a no gold standard for assess-
ment exists due to inherent limitations of the avail-
able techniques [4, 20]. Another problem in daily
business is the lack of standardized methods in CDI
Table 3 Test performance characteristics of included studies
Name, year Vessel Pathology TP FP FN TN Sensitivity Specificity negative LR (95% CI) positive LR (95% CI)
Han-Hwa Hu, 1993 [10] oaa 0 21 20 4 87 85.70% 80.90% 0.197 (0.080 to 0.485) 4.49 (2.92 to 6.91)
Jimenez-Aragon, 2013 [14] oa 2 7 6 5 53 54.60% 90.00% 0.464 (0.236 to 0.911) 5.74 (2.34 to 14.06)
Martinez, 2005 [15] oa 2 19 2 4 24 82.60% 92.30% 0.188 (0.077 to 0.462) 10.74 (2.80 to 41.21)
Suprasanna, 2014 [16] oa 2 24 9 1 44 96.00% 83.00% 0.048 (0.007 to 0.330) 5.65 (3.10 to 10.31)
Basturk, 2012 [13] oa 1 40 20 11 47 78.40% 70.00% 0.307 (0.178 to 0.531) 2.63 (1.77 to 3.90)
Paivansalo, 1999 [11] oa 0 13 2 35 44 27.00% 96.00% 0.762 (0.635 to 0.915) 6.23 (1.49 to 26.10)
Arai, 1998 [12] oa 1 14 8 11 19 56.00% 72.00% 0.625 (0.377 to 1.037) 1.89 (0.96 to 3.72)
Jimenez-Aragon, 2013 [14] craa 2 6 4 6 55 50.00% 94.00% 0.536 (0.303 to 0.948) 7.38 (2.45 to 22.21)
Arai, 1998 [12] cra 1 16 10 9 17 64.00% 63.00% 0.572 (0.315 to 1.039) 1.73 (0.97 to 3.06)
Han-Hwa Hu, 1993 [10] cra 0 21 11 4 96 84.00% 89.60% 0.178 (0.072 to 0.439) 8.17 (4.55 to 14.67)
Paivansalo, 1999 [11] cra 0 15 6 33 40 31.00% 88.00% 0.791 (0.634 to 0.986) 2.4 (1.02 to 5.64)
Arsène, 2002 [18] cra 3 48 11 21 22 70.00% 66.00% 0.457 (0.297 to 0.702) 2.09 (1.26 to 3.47)
Plange, 1999 [17] cra 2 30 4 32 36 48.40% 90.00% 0.573 (0.441 to 0.745) 4.84 (1.84 to 12.70)
Tranquart, 1999 [19] crva 3 12 18 6 33 67.00% 65.00% 0.515 (0.260 to 1.021) 1.89 (1.15 to 3.10)
Williamson, 1994 [6] crv 3 6 3 2 19 75.00% 86.00% 0.289 (0.086 to 0.972) 5.5 (1.79 to 16.94)
TP true positives, FP false positives, FN false negatives, TN true negatives, LR likelihood ratio, CI confidence interval
aoa ophthalmic artery, cra central retinal artery, crv central retinal vein
Pathology: 0 = central carotic stenosis; 1 = diabetes; 2 = glaucoma; 3 = central retinal vein occlusion
Fig. 2 Hierarchical summary ROC curve of studies assessing Ophthalmic (left) and Central retinal (right) artery
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assessment as Stalmans et al. already indicated [21].
Despite the vast amount of studies assessing ocular
diseases, only a minority quantifies the CDI’s accur-
acy, impeding judgments regarding its value in the
diagnostic work-up of ocular pathologies.
Results in context of existing literature
To our knowledge, this is the first comprehensive
assessment of studies examining the diagnostic value
of CDI in ocular diseases. We are aware of one
meta-analysis of studies dealing with hemodynamic
changes in ophthalmic artery and central retinal ar-
tery using CDI in Chinese patients with glaucoma
[22]. However, this meta-analysis does not assess the
diagnostic value using test accuracy data of CDI in
glaucomatous patients [23]. In contrast to our find-
ings, Dimitrova et al. [2] published a review stating
CDI as a valuable tool in a wide range of ophthal-
mologic diseases for research and as a potentially
useful diagnostic tool in the clinical setting.
Although CDI appears to be a useful tool in the
research of ocular blood flow changes, especially in
glaucoma, diabetic retinopathy and age related
macular degeneration [24–29], implementation in
daily use as a diagnostic tool concerning the path-
ologies assessed in our study cannot be recom-
mended yet.
Strengths and limitations
Our study applied up-to-date systematic review
methodology, allowing a comprehensive description
of the existing diagnostic literature on CDI test ac-
curacy in ophthalmology. Due to the limited number
of studies and the small number of participants in
the included studies more upstream and formally
sound (statistical) analyses were not feasible. We
performed exploratory analyses to give an overview
of the diagnostic performance of the CDI. However,
the analysis has major limitations due to the mix of
studies investigating different conditions and some
methodological weaknesses of the underlying studies.
Also, no analysis of the impact of different CDI sys-
tems on diagnostic performance could be performed
due to the paucity of data. Hence we could not go
beyond a mere description of the evidence.
Implications for further research
For successful implementation in clinical care, stan-
dards of CDI assessment need to be introduced to
form the basis of a consistent assessment tool and to
decrease the potential inter-rater reliability issues.
There are promising results of altered ocular blood
flow in common ocular diseases like diabetic retinop-
athy, age related macular disease and several forms
of glaucoma [24, 27–31] and growing evidence show-
ing that ocular blood flow alterations are associated
with the development and progression of ophthalmo-
logic diseases confirm the notion that abnormalities
in vessel function exist before the development of
structural changes occur. Considering this exciting
point of view it seems promising to focus research
of preclinical changes of ocular blood flow and
prediction of progression of respective diseases. In
order to fully understand underlying pathophysio-
logical mechanisms and to offer timely treatments
further studies are needed to fill in the current lack
of knowledge.
Implications for practice
For the pathologies assessed in our analysis, im-
plementation of CDI as a diagnostic tool in clinical
practice does not seem helpful. Current available
diagnostic tools like slit lamp examination, fluores-
cence angiography, visual field analysers and scanning
laser polarimetry seem to be superior and more prac-
ticable compared with CDI. In case of glaucoma, the
diagnosis relies on the assessment of intraocular
changes occurring in the visual field, the optic nerve
head, and the retinal nerve fibre layer. Perimetry is
the current gold standard of progression as it enables
the detection of small glaucomatous changes to the
visual field. However, perimetry is limited by low
diagnostic sensitivity in early stages of the disease
[32] and there is a need for assessment techniques
capable of detecting preclinical stages of the disease.
In case of retinal vein occlusion fundoscopy and
fluorescence angiography are satisfying diagnostic
tools. However, predicting ischemic areas using alter-
ations of ocular blood flow could be a valuable non-
invasive tool. Regarding diabetic retinopathy, again,
slit lamp examination and fluorescence angiography
are valuable diagnostic tools superior to CDI. How-
ever, early detection of altered blood flow could
improve implementation of therapy in early stages of
the disease.
Conclusions
The possible role of colour Doppler analysis in
routine ophthalmologic care remains unclear. The
relative lack of robust assessments of the diagnostic
value of colour Doppler analysis, limits the possibil-
ities to extrapolate its true potential for clinical
practice.
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